LLY
742.34
+2.24%↑
UNH
524.47
+2.96%↑
JNJ
148.01
+0.7%↑
ABBV
172.39
+0.6%↑
NVO
80.97
+2.85%↑
LLY
742.34
+2.24%↑
UNH
524.47
+2.96%↑
JNJ
148.01
+0.7%↑
ABBV
172.39
+0.6%↑
NVO
80.97
+2.85%↑
LLY
742.34
+2.24%↑
UNH
524.47
+2.96%↑
JNJ
148.01
+0.7%↑
ABBV
172.39
+0.6%↑
NVO
80.97
+2.85%↑
LLY
742.34
+2.24%↑
UNH
524.47
+2.96%↑
JNJ
148.01
+0.7%↑
ABBV
172.39
+0.6%↑
NVO
80.97
+2.85%↑
LLY
742.34
+2.24%↑
UNH
524.47
+2.96%↑
JNJ
148.01
+0.7%↑
ABBV
172.39
+0.6%↑
NVO
80.97
+2.85%↑
24h
Current
Min
23.3
Max
24.57
Recommendations | Buy |
---|---|
12 Months Forecast | +113.31 upside |
Next Earnings | 25 Feb 2025 |
---|
By Acuity
69%
31%
350 / 392 Healthcare
By Trading Central
Confidence
Bearish Evidence
23.39 / 25.59 Support & Resistance
Past performance is not a reliable indicator of future results.
26 Sept 2024, 14:20 UTC
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit. -- IBD
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 50 USD 113.31%
High 80 USD
Low 24 USD
Based on 15 Wall Street analysts offering 12 month price targets forBeam Therapeutics Inc - Dist in the last 3 months.
By TipRanks
Buy
15 ratings
10
Buy
5
Hold
0
Sell
Based on 15 analysts giving stock ratings to Beam Therapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
$